Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy

被引:8
|
作者
Lin, Baiqiang [3 ]
Zhao, Fuya [3 ,6 ]
Liu, Yang [1 ,2 ,3 ]
Sun, Jiayu [3 ,7 ]
Feng, Jing [3 ]
Zhao, Lei [3 ]
Wang, Haoran [3 ]
Chen, Hongye [3 ]
Yan, Wei [3 ]
Guo, Xiao [3 ]
Shi, Shang [3 ]
Li, Zhiyong [3 ]
Wang, Shuang [3 ]
Lu, Yu [3 ]
Zheng, Jianjun [4 ,5 ]
Wei, Yunwei [1 ,2 ,3 ]
机构
[1] Univ Chinese Acad Sci, HwaMei Hosp, Pancreat & Gastrointestinal Surg Div, Ningbo, Peoples R China
[2] Ningbo Clin Res Ctr Digest Syst Tumors, Ningbo, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 1, Oncol & Laparoscopy Surg, Harbin, Peoples R China
[4] Univ Chinese Acad Sci, HwaMei Hosp, Imaging Ctr, Ningbo, Peoples R China
[5] Ningbo Clin Med Res Ctr Imaging Med, Ningbo, Peoples R China
[6] Fujian Med Univ, Affiliated Hosp 1, Gastrointestinal Surg, Fuzhou, Peoples R China
[7] SouthernMed Univ, Zhujiang Hosp, Gen Surg, Guangzhou, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
oral microbiota; xerostomia; differentiated thyroid carcinoma; radioiodine therapy; 16S rRNA; SALIVARY-GLAND FUNCTION; RADIOACTIVE IODINE; CANCER; INFLAMMATION; LIPOPOLYSACCHARIDE; RADIATION; CAVITY;
D O I
10.3389/fendo.2022.895970
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and AimsOral xerostomia remains one of the most common complications of differentiated thyroid carcinoma patients (DTC) after radioiodine therapy (RAI). Environmental factors in the etiology of xerostomia are largely unknown. We aimed to characterize the oral microbiota signatures and related biological functions associated with xerostomia and identify environmental factors affecting them. MethodsSaliva was collected from 30 DTC patients with xerostomia (XAs), 32 patients without xerostomia (indicated as non-XAs) following RAI after total thyroidectomy, and 40 healthy people (HCs) for 16S rRNA sequencing analysis. ResultsThe oral microbiota of XAs and non-XAs exhibited significant differences in alpha and beta diversities and bacterial taxa. The abundance of porphyromonas, fusobacterium, and treponema_2 were significantly higher in XAs, while the abundance of the streptococcus was lower in the microbiota of non-XAs. Fusobacterium, and porphyromonas were negatively correlated with unstimulated/stimulated whole salivary secretion (USW)/(SWS), while fusobacterium, porphyromonas, and treponema_2 genera levels were positively associated with cumulative radioiodine dose. PICRUSt2 and BugBase suggested a significant difference in the expression of potentially_pathogenic, anaerobic, gram_negative, the arachidonic acid metabolism, and lipopolysaccharide (LPS) biosynthesis between XAs and non-XAs, possibly interdependent on radioiodine-induced inflammation. NetShift analysis revealed that porphyromonas genus might play as a key driver during the process of xerostomia. Five genera effectively distinguished XAs from non-XAs (AUC = 0.87). ConclusionOur study suggests for the first time that DTC patients with xerostomia after RAI display microbiota profiles and associated functional changes that may promote a pro-inflammatory environment. Dysbiosis of the oral microbiota may contribute to exacerbating the severity of xerostomia. Our results provide a research direction of the interaction mechanism between oral microbiota alteration and the progress of xerostomia.
引用
收藏
页数:14
相关论文
共 50 条
  • [11] TIME COURSE OF THYROGLOBULIN AUTOANTIBODIES IN PATIENTS WITH DIFFERENTIATED THYROID-CARCINOMA AFTER RADIOIODINE THERAPY
    MOSER, E
    BRAUN, S
    KIRSCH, CM
    KLEINHANS, E
    BUELL, U
    NUCLEAR MEDICINE COMMUNICATIONS, 1984, 5 (05) : 317 - 321
  • [12] Radioiodine therapy of differentiated thyroid carcinoma and recurrences of disease
    Stefanovic, L.
    Mihailovic, J.
    Malesevic, M.
    Nikoletic, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S331 - S331
  • [13] Radioiodine therapy for well-differentiated thyroid carcinoma
    Schicha, H
    Dietlein, M
    ZENTRALBLATT FUR CHIRURGIE, 1997, 122 (04): : 266 - 273
  • [14] High activity radioiodine therapy for differentiated thyroid carcinoma
    Carnell, D
    McCready, R
    Harmer, C
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 260P - 261P
  • [15] Primary presentation and clinical course of pediatric and adolescent patients with differentiated thyroid carcinoma after radioiodine therapy
    Burgard, Caroline
    Zacherl, Mathias Johannes
    Todica, Andrei
    Hornung, Julia
    Grawe, Freba
    Pekrul, Isabell
    Zimmermann, Petra
    Schmid-Tannwald, Christine
    Ladurner, Roland
    Krenz, Detlef
    Trupka, Arnold
    Wagner, Johanna
    Bartenstein, Peter
    Spitzweg, Christine
    Wenter, Vera
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [16] Physical and Biological DNA Dosimetry after Radioiodine Therapy of Patients with Differentiated Thyroid Carcinoma: First Results
    Lassmann, M.
    Haenscheid, H.
    Lorenz, R.
    Nerlich, K.
    Verburg, E.
    Meineke, V.
    Reiners, C.
    Scherthan, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S196 - S196
  • [17] Lung metastases in patients with differentiated thyroid carcinoma and evaluation of response to radioiodine therapy
    Kalender, E.
    Celen, Y. Zeki
    Elboga, U.
    Demir, H. Deniz
    Yilmaz, M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2012, 31 (06): : 328 - 331
  • [18] The Effect of Radioiodine Therapy on Ovarian Function in Patients th Differentiated Thyroid Carcinoma
    Lin, Rong
    Miao, Weibing
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [19] 131I-SPECT/CT after radioiodine therapy in patients with differentiated thyroid carcinoma (DTC)
    Nuvoli, S.
    Marongiu, A.
    Gelo, I.
    Mele, L.
    Rondini, M.
    Stazza, M. L.
    Madeddu, G.
    Spanu, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S698 - S699
  • [20] Glycididazole sodium combined with radioiodine therapy for patients with differentiated thyroid carcinoma (DTC)
    Wen, Qiang
    Ma, Qingjie
    Bai, Lin
    Wang, Tongtong
    Han, Yuping
    Zhang, Haishan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (08): : 14095 - 14099